cremophor el has been researched along with topotecan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camlett, I; de Jonge, MJ; Gelderblom, H; Hennis, B; Loos, WJ; Mantel, MA; Sparreboom, A; van der Burg, ME; Verweij, J; Wilms, E | 1 |
| Katsumi, H; Kusamori, K; Morishita, M; Sakane, T; Sawangrat, K; Tanaka, A; Yamamoto, A; Yamashita, S | 1 |
1 trial(s) available for cremophor el and topotecan
| Article | Year |
|---|---|
Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Glycerol; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Topotecan | 2001 |
1 other study(ies) available for cremophor el and topotecan
| Article | Year |
|---|---|
Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Availability; Caco-2 Cells; Excipients; Glycerides; Glycerol; Humans; Intestinal Absorption; Lipid Bilayers; Male; Neoplasm Proteins; Poloxamer; Polysorbates; Rats; Topotecan | 2019 |